Goldman Sachs’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-68
| Closed | -$718 | – | 4917 |
|
2023
Q4 | $718 | Sell |
68
-286
| -81% | -$3.02K | ﹤0.01% | 4749 |
|
2023
Q3 | $7K | Sell |
354
-5
| -1% | -$99 | ﹤0.01% | 4628 |
|
2023
Q2 | $27.5K | Sell |
359
-22
| -6% | -$1.68K | ﹤0.01% | 4723 |
|
2023
Q1 | $36K | Sell |
381
-773
| -67% | -$73K | ﹤0.01% | 4810 |
|
2022
Q4 | $112K | Sell |
1,154
-627
| -35% | -$61K | ﹤0.01% | 4649 |
|
2022
Q3 | $460K | Buy |
1,781
+520
| +41% | +$134K | ﹤0.01% | 4298 |
|
2022
Q2 | $0 | Sell |
1,261
-29,116
| -96% | – | ﹤0.01% | 5850 |
|
2022
Q1 | $2.97M | Buy |
30,377
+27,101
| +827% | +$2.65M | ﹤0.01% | 3248 |
|
2021
Q4 | $536K | Buy |
3,276
+330
| +11% | +$54K | ﹤0.01% | 4465 |
|
2021
Q3 | $804K | Buy |
2,946
+408
| +16% | +$111K | ﹤0.01% | 4122 |
|
2021
Q2 | $1.01M | Buy |
2,538
+204
| +9% | +$80.8K | ﹤0.01% | 4006 |
|
2021
Q1 | $1.26M | Sell |
2,334
-404
| -15% | -$218K | ﹤0.01% | 3755 |
|
2020
Q4 | $1.04M | Sell |
2,738
-10,504
| -79% | -$3.97M | ﹤0.01% | 3438 |
|
2020
Q3 | $5.01M | Buy |
13,242
+627
| +5% | +$237K | ﹤0.01% | 2386 |
|
2020
Q2 | $6.21M | Buy |
12,615
+10,539
| +508% | +$5.18M | ﹤0.01% | 2220 |
|
2020
Q1 | $763K | Buy |
2,076
+219
| +12% | +$80.5K | ﹤0.01% | 3260 |
|
2019
Q4 | $1.32M | Sell |
1,857
-356
| -16% | -$252K | ﹤0.01% | 3176 |
|
2019
Q3 | $1.42M | Buy |
2,213
+1,123
| +103% | +$721K | ﹤0.01% | 3040 |
|
2019
Q2 | $953K | Buy |
1,090
+208
| +24% | +$182K | ﹤0.01% | 3223 |
|
2019
Q1 | $510K | Buy |
882
+131
| +17% | +$75.7K | ﹤0.01% | 3556 |
|
2018
Q4 | $211K | Sell |
751
-62
| -8% | -$17.4K | ﹤0.01% | 3722 |
|
2018
Q3 | $390K | Sell |
813
-182
| -18% | -$87.3K | ﹤0.01% | 3549 |
|
2018
Q2 | $450K | Buy |
995
+559
| +128% | +$253K | ﹤0.01% | 3570 |
|
2018
Q1 | $256K | Sell |
436
-533
| -55% | -$313K | ﹤0.01% | 3756 |
|
2017
Q4 | $601K | Sell |
969
-98
| -9% | -$60.8K | ﹤0.01% | 3371 |
|
2017
Q3 | $982K | Buy |
1,067
+894
| +517% | +$823K | ﹤0.01% | 3227 |
|
2017
Q2 | $162K | Sell |
173
-569
| -77% | -$533K | ﹤0.01% | 4037 |
|
2017
Q1 | $706K | Sell |
742
-737
| -50% | -$701K | ﹤0.01% | 3309 |
|
2016
Q4 | $1.19M | Sell |
1,479
-295
| -17% | -$237K | ﹤0.01% | 2995 |
|
2016
Q3 | $1.5M | Buy |
1,774
+839
| +90% | +$708K | ﹤0.01% | 2843 |
|
2016
Q2 | $770K | Sell |
935
-193
| -17% | -$159K | ﹤0.01% | 3088 |
|
2016
Q1 | $1.26M | Sell |
1,128
-450
| -29% | -$501K | ﹤0.01% | 2756 |
|
2015
Q4 | $1.97M | Buy |
1,578
+484
| +44% | +$603K | ﹤0.01% | 2530 |
|
2015
Q3 | $1.48M | Sell |
1,094
-1,222
| -53% | -$1.65M | ﹤0.01% | 2705 |
|
2015
Q2 | $4.17M | Buy |
2,316
+839
| +57% | +$1.51M | ﹤0.01% | 2169 |
|
2015
Q1 | $2.39M | Buy |
1,477
+220
| +18% | +$355K | ﹤0.01% | 2435 |
|
2014
Q4 | $956K | Buy |
1,257
+443
| +54% | +$337K | ﹤0.01% | 2961 |
|
2014
Q3 | $322K | Buy |
814
+669
| +461% | +$265K | ﹤0.01% | 3611 |
|
2014
Q2 | $88K | Sell |
145
-74
| -34% | -$44.9K | ﹤0.01% | 4214 |
|
2014
Q1 | $150K | Sell |
219
-420
| -66% | -$288K | ﹤0.01% | 4042 |
|
2013
Q4 | $416K | Sell |
639
-248
| -28% | -$161K | ﹤0.01% | 3522 |
|
2013
Q3 | $524K | Sell |
887
-345
| -28% | -$204K | ﹤0.01% | 3312 |
|
2013
Q2 | $390K | Buy |
+1,232
| New | +$390K | ﹤0.01% | 3307 |
|